Kadell AM - Search Results

1

Heparin-mediated reductions of the toxic effects of protamine sulfate on rabbit myocardium.

Wakefield TW, Wrobleski SK, Nichol BJ, Kadell AM, Stanley JC. Wakefield TW, et al. Among authors: kadell am. J Vasc Surg. 1992 Jul;16(1):47-53. J Vasc Surg. 1992. PMID: 1619724

2

Effective and less toxic reversal of low-molecular weight heparin anticoagulation by a designer variant of protamine.

Wakefield TW, Andrews PC, Wrobleski SK, Kadell AM, Schmidt R, Tejwani S, Stanley JC. Wakefield TW, et al. Among authors: kadell am. J Vasc Surg. 1995 May;21(5):839-49; discussion 849-50. doi: 10.1016/s0741-5214(05)80016-3. J Vasc Surg. 1995. PMID: 7769743 Free article.

3

Reversal of low-molecular-weight heparin anticoagulation by synthetic protamine analogues.

Wakefield TW, Andrews PC, Wrobleski SK, Kadell AM, Fazzalari A, Nichol BJ, Vanderkooi T, Stanley JC. Wakefield TW, et al. Among authors: kadell am. J Surg Res. 1994 Jun;56(6):586-93. doi: 10.1006/jsre.1994.1093. J Surg Res. 1994. PMID: 8015315 Free article.

4

Tissue distribution, circulating half-life, and excretion of intravenously administered protamine sulfate.

DeLucia A 3rd, Wakefield TW, Kadell AM, Wrobleski SK, VanDort M, Stanley JC. DeLucia A 3rd, et al. Among authors: kadell am. ASAIO J. 1993 Jul-Sep;39(3):M715-8. ASAIO J. 1993. PMID: 8268631

5

Efficacy and toxicity of differently charged polycationic protamine-like peptides for heparin anticoagulation reversal.

DeLucia A 3rd, Wakefield TW, Andrews PC, Nichol BJ, Kadell AM, Wrobleski SK, Downing LJ, Stanley JC. DeLucia A 3rd, et al. Among authors: kadell am. J Vasc Surg. 1993 Jul;18(1):49-58; discussion 58-60. doi: 10.1067/mva.1993.42736. J Vasc Surg. 1993. PMID: 8326659

6

A [+18RGD] protamine variant for nontoxic and effective reversal of conventional heparin and low-molecular-weight heparin anticoagulation.

Wakefield TW, Andrews PC, Wrobleski SK, Kadell AM, Tejwani S, Hulin MS, Stanley JC. Wakefield TW, et al. Among authors: kadell am. J Surg Res. 1996 Jun;63(1):280-6. doi: 10.1006/jsre.1996.0261. J Surg Res. 1996. PMID: 8661211

7

Comparison of the hemodynamic and hematologic toxicity of a protamine variant after reversal of low-molecular-weight heparin anticoagulation in a canine model.

Hulin MS, Wakefield TW, Andrews PC, Wrobleski SK, Kadell AM, Downing LJ, Stanley JC. Hulin MS, et al. Among authors: kadell am. Lab Anim Sci. 1997 Apr;47(2):153-60. Lab Anim Sci. 1997. PMID: 9150494

8

Low-dose low-molecular-weight heparin is anti-inflammatory during venous thrombosis.

Downing LJ, Strieter RM, Kadell AM, Wilke CA, Greenfield LJ, Wakefield TW. Downing LJ, et al. Among authors: kadell am. J Vasc Surg. 1998 Nov;28(5):848-54. doi: 10.1016/s0741-5214(98)70060-6. J Vasc Surg. 1998. PMID: 9808852 Free article.

9

Neovascularization during venous thrombosis organization: a preliminary study.

Wakefield TW, Linn MJ, Henke PK, Kadell AM, Wilke CA, Wrobleski SK, Sarkar M, Burdick MD, Myers DD, Strieter RM. Wakefield TW, et al. Among authors: kadell am. J Vasc Surg. 1999 Nov;30(5):885-92. doi: 10.1016/s0741-5214(99)70013-3. J Vasc Surg. 1999. PMID: 10550186 Free article.

10

Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy.

Wakefield TW, Strieter RM, Schaub R, Myers DD, Prince MR, Wrobleski SK, Londy FJ, Kadell AM, Brown SL, Henke PK, Greenfield LJ. Wakefield TW, et al. Among authors: kadell am. J Vasc Surg. 2000 Feb;31(2):309-24. doi: 10.1016/s0741-5214(00)90162-9. J Vasc Surg. 2000. PMID: 10664500 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters